Is the liver damage caused by dolutegravir sodium tablets severe?

In general, whether dolutegravir sodium tablets cause significant liver damage depends on the individual patient's specific condition. If any discomfort occurs, it is recommended to seek medical attention promptly. The detailed analysis is as follows:

For patients with normal baseline liver function, no history of chronic liver disease, who strictly follow medical instructions and do not take other hepatotoxic medications concurrently, dolutegravir sodium tablets usually pose minimal risk to the liver. In clinical practice, liver function indicators in such patients typically remain stable after starting the medication. The drug’s metabolism does not excessively burden the liver, allowing for safe use under regular monitoring.

However, for patients with pre-existing liver conditions such as chronic hepatitis or cirrhosis, or those who increase their dosage without guidance or concomitantly use other hepatotoxic drugs (e.g., antifungal agents), the risk of liver injury increases. In these cases, impaired liver metabolism may lead to accumulation of the drug and its metabolites, potentially causing elevated transaminase levels or even liver failure.

During treatment, patients should maintain a light diet, avoid alcohol and high-fat foods, have liver function tests regularly, adjust medication regimens as directed by a physician, and seek immediate medical care if symptoms such as fatigue or jaundice occur.